OncLive TV

OncLive® TV is an editorial video program featuring one-on-one live and/or virtual interviews with key opinion leaders in the oncology field for their expert insight on breaking news, regulatory updates, practice-changing data presented at medical meetings, and other pivotal topics in a cancer specialty, including breast cancer, lung cancer, genitourinary cancers, gastrointestinal cancers, gynecologic cancers, and hematologic cancers.

Dr. Lilenbaum on the Rise of Immunotherapy in NSCLC

May 16th 2020

Rogerio C. Lilenbaum, MD, discusses the rise of immunotherapy in non–small cell lung cancer.

Dr. Donington on the Role of Neoadjuvant Immunotherapy in Stage II NSCLC

May 15th 2020

Jessica Donington, MD, MSCR, discusses the role of neoadjuvant immunotherapy in patients with stage II non–small cell lung cancer.

Dr. Chaft on Immune-Related AEs in NSCLC

May 15th 2020

Jamie E. Chaft, MD, discusses immune-related adverse effects in non–small cell lung cancer.

Dr. Lilenbaum on the Rise of Immunotherapy in NSCLC

May 15th 2020

Rogerio C. Lilenbaum, MD, discusses the rise of immunotherapy in non–small cell lung cancer.

CLR 131 Mechanism of Action

May 15th 2020

Dr. Lopes on the FDA Approval of Nivolumab/Ipilimumab in NSCLC

May 15th 2020

Gilberto De Lima Lopes, MD, discusses the FDA approval of nivolumab (Opdivo) and ipilimumab (Yervoy) in non–small cell lung cancer (NSCLC).

Dr. Daver on Anticipated Breakthroughs in AML

May 15th 2020

Naval G. Daver, MD, discusses anticipated breakthroughs in acute myeloid leukemia (AML).

Dr. Penson on Ongoing Research in Prostate Cancer

May 15th 2020

David F. Penson, MD, MPH, MMHC, discusses ongoing research in prostate cancer.

Dr. Dahut on the Future of Genetic Screening in Prostate Cancer

May 15th 2020

William L. Dahut, MD, discusses the future of genetic screening in prostate cancer.

Dr. Huh on SGO COVID-19 Task Force Efforts

May 15th 2020

Warner K. Huh, MD, discusses some of the key challenges faced in the management of gynecologic cancers in light of the COVID-19 crisis, shares some of the resources provided by the SGO COVID-19 task force, and projects what is needed to quell the pandemic, which he refers to as version of the Great Depression.

Dr. Wright on Radiation Considerations in Breast Cancer

May 15th 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

Dr. Natale on the Evolution of Immunotherapy in NSCLC

May 15th 2020

Ronald B. Natale, MD, discusses the evolution of immunotherapy in advanced non–small cell lung cancer.

Dr. Zelenetz on Progress Made in MCL Treatment

May 15th 2020

Andrew D. Zelenetz, MD, PhD, discusses progress made in mantle cell lymphoma treatment.

Dr. Noy on Next Phase of a Trial With Devimistat in Relapsed/Refractory Burkitt Lymphoma

May 15th 2020

Ariela Noy, MD, discusses the next phase of a trial with devimistat in patients with relapsed/refractory Burkitt lymphoma.

Dr. Daver on Anticipated Breakthroughs in AML

May 15th 2020

Naval G. Daver, MD, discusses anticipated breakthroughs in acute myeloid leukemia (AML).

Dr. Ghorbrial on the Potential Utility of Triplet Therapy in Smoldering Multiple Myeloma

May 15th 2020

Irene Ghobrial, MD, discusses the potential utility of triplet therapy in smoldering multiple myeloma.

Dr. Penson on Ongoing Research in Prostate Cancer

May 14th 2020

David F. Penson, MD, MPH, MMHC, discusses ongoing research in prostate cancer.

Dr. Dahut on the Future of Genetic Screening in Prostate Cancer

May 14th 2020

William L. Dahut, MD, discusses the future of genetic screening in prostate cancer.

The Rationale for Investigating DNA-PK as a Target in Prostate Cancer

May 14th 2020

Karen E. Knudsen, PhD, discusses the rationale for investigating DNA-dependent protein kinase as a target in prostate cancer.

Dr. Huh on SGO COVID-19 Task Force Efforts

May 14th 2020